SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 25th, 2021 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 25th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 21, 2021, between Genetic Technologies Limited, an Australian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).